Regula Furegati Hafner: Katalogdaten im Frühjahrssemester 2020 |
| Name | Frau Regula Furegati Hafner |
| Adresse | Inst. f. Pharmazeutische Wiss. ETH Zürich, HCI H 417 Vladimir-Prelog-Weg 1-5/10 8093 Zürich SWITZERLAND |
| Telefon | +41 44 633 74 05 |
| Fax | +41 44 633 13 65 |
| regula.furegati@pharma.ethz.ch | |
| URL | http://www.postgraduate.pharma.ethz.ch |
| Departement | Chemie und Angewandte Biowissenschaften |
| Beziehung | Dozentin |
| Nummer | Titel | ECTS | Umfang | Dozierende | |
|---|---|---|---|---|---|
| 541-0001-00L | Module 1: Health System, Pharmabusiness and Marketing Only for CAS in Pharmaceuticals. The enrolment is done by the CAS in Pharmaceuticals study administration. | 2.5 KP | 3G | R. Furegati Hafner, R. Schibli | |
| Kurzbeschreibung | Students learn about the different health systems, primarily about the European and the Swiss specialities, then also in comparison with the US system. A short introduction is made about Marketing with focus on Pharma, the legislation and patents/licencing are discussed and pharmacooeconomic aspects and business development are explained and intensified through workshops. | ||||
| Lernziel | Pharmabusiness and Corporate Governance; Pharmamarketing with workshop; Healthcare systems in Switzerland and in the EU; Pharmacoeconomics with workshop; Data integrity for supply chain powered by blockchain; Opinion Leader Management, Workshop; Legislation; Patents and licences; Building Pharma 4.0 – Future Directions; Market Access, Pricing and Reimbursement; Business Development: Connected Health; | ||||
| Skript | Course documents in print and a link to the electronic version are distributed during the module. | ||||
| 541-0003-00L | Module 3: Quality and GMP Only for CAS in Pharmaceuticals. The enrolment is done by the CAS in Pharmaceuticals study administration. | 2.5 KP | 3G | R. Furegati Hafner, R. Schibli | |
| Kurzbeschreibung | |||||
| Lernziel | |||||
| 541-1000-00L | Essay Nur für CAS in Pharmaceuticals. Einschreibung nur über das Sekretariat des CAS in Pharmaceuticals. | 1 KP | 2D | R. Furegati Hafner, R. Schibli | |
| Kurzbeschreibung | The essay is an essential part of the CAS program „Pharmaceuticals – From Research to Market“ (CAS Pharm) and serves as final performance assessment. | ||||
| Lernziel | The essay documents the student’s competence development during the program as well as the transfer of acquired knowledge to professional practice/activities. | ||||
| 542-0002-00L | Module II: Radiopharmaceutical Chemistry Only for CAS in Radiopharmazeutischer Chemie, Radiopharmacy. The enrolment is done by the CAS study administration. | 4 KP | 6G | R. Furegati Hafner, R. Schibli | |
| Kurzbeschreibung | This postgraduate certificate course consists of three 2-week-modules and enables natural scientists to assume responsibility for the small-batch production and quality control of radiopharmaceuticals. Module II: Radiopharmaceutical Chemistry 6 x 4hours of laboratory practice in different locations (PSI, ETH Hönggerberg) | ||||
| Lernziel | • Introduction to radiopharmacy and physics • Radionuclide production • Generator systems • In vitro- and in vivo-characterization of radiolabelled peptides and antibodies • The chemistry of Tc and Re • Kits and pitfalls • Radiopharmaceutical chemistry with halogen isotopes • 18F- and 11C-radiolabelled pharmaceuticals • Chemistry of radiometals other than Tc and Re • Animal and in vitro models • Practical sessions: • Radiolabelling and quality control of antibodies • Mo/Tc-generator and use of kits including quality control and preclinical application • Ge/Ga-generator and 68Ga-radiolabelling of peptides including quality control/video cell labelling • Insight into the routine manufacturing of clinical PET radiopharmaceuticals • 11C- and 18F- radiolabelling for research • In vitro/preclinical characterization of PET radiopharmaceuticals | ||||